Abstract
BackgroundPD-1 (CD279) is an immune checkpoint inhibitor that is expressed on the surface of T cells. Therapies inhibiting PD-1 interactions have become the most popular checkpoint inhibitor utilized in cancer...
Paper version not known (Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have